All Sections

Site Selection

Facility Planning

Workforce Development

Business+Place

AD Editorial Board

Alan Reeves

Senior Managing Director, Global Strategy, Newmark
Alexandra Segers

General Manager, Tochi Advisors
Amy Gerber

Executive Managing Director, Business Incentives Practice, Cushman & Wakefield
Bradley Migdal

Executive Managing Director, Americas Strategic Consulting, Cushman & Wakefield
Brian Corde

Managing Partner, Atlas Insight
Brian Gallagher

Vice President, Corporate Strategy and Development, PPC Partners, Inc.
Chris Chmura, Ph.D.

CEO & Founder, Chmura Economics
Chris Schwinden

Partner, Site Selection Group
Chris Volney

Managing Director, Americas Consulting, CBRE
Courtland Robinson

Director of Business Development, Brasfield & Gorrie
Courtney Dunbar

Site Selection & Economic Development Leader, Burns & McDonnell
David Hickey

Managing Director, Hickey & Associates
Dennis Cuneo

Former Senior Vice President, Toyota Motor North America; Owner , DC Strategic Advisors
Dianne Jones

Managing Director, Business and Economic Incentives, JLL
Eric Stavriotis

Vice Chairman, CBRE
Joe Dunlap

Chief Supply Chain Officer, Legacy Investing
Lauren Berry

Senior Manager, Location Analysis and Incentives, Maxis Advisors
Marc Beauchamp

President, SCI Global
Matthew Powers

Site Selection Lead, REDI Site Selection
Scott J. Ziance

Partner and Economic Incentives Practice Leader, Vorys, Sater, Seymour and Pease LLP
Scott Kupperman

Founder, Kupperman Location Solutions
Stephen Gray

President & CEO, Gray Construction

Cardinal Biologicals Expands Cape Girardeau, Missouri, Operations

Area Development News Desk

10/27/2025

Cardinal Biologicals, a producer of medical-grade biologics, plans to expand its operations in Cape Girardeau, Missouri. The $2.74 million project is expected to create six jobs.

The investment will include the addition of a new water-based lab consumables production line at the company’s existing Cape Girardeau headquarters as well as the opening of offices in Springfield and Joplin.

“We appreciate the support of SEMO REDI and the Missouri Department of Economic Development,” said Anthony Dunning, Operations Director for Cardinal Biologicals. “The payroll savings and export guidance were a nice boost as we look to grow the operation.”

To support the project Cardinal Biologicals will benefit from the Missouri Works program, a tool that helps companies expand and retain workers by providing access to capital through withholdings or tax credits for job creation.

“DED is thrilled to support Cardinal Biologicals as it expands in multiple Missouri locations and reaches a global audience,” noted Michelle Hataway, Director of the Department of Economic Development. “It’s always exciting to see forward-thinking companies investing locally and taking their business to the next level while helping Missourians prosper in the process.”

Cardinal Biologicals is a biotechnology research company that supplies human biological materials, such as organs, tissues, serum, plasma, and umbilical cord, to the life sciences, research, and diagnostic sectors.

“Any time you’re thinking about expanding, it pays to explore Missouri Works,” added Shad Burner, CEO of SEMO REDI. “Payroll-tax savings alone can deliver significant value and help companies keep investment and jobs right here in Southeast Missouri.”

Project Announcements